Literature DB >> 22106977

Comparative risk of microalbuminuria and proteinuria in UK residents of south Asian and white European ethnic background with type 2 diabetes: a report from UKADS.

Neil T Raymond1, J Paul O'Hare, Srikanth Bellary, Sudhesh Kumar, Alan Jones, Anthony H Barnett.   

Abstract

OBJECTIVE: This study investigated and compared the prevalence of microalbuminuria and overt proteinuria and their determinants in a cohort of UK resident patients of white European or south Asian ethnicity with type 2 diabetes mellitus. RESEARCH DESIGN AND METHODS: A total of 1978 patients, comprising 1486 of south Asian and 492 of white European ethnicity, in 25 general practices in Coventry and Birmingham inner city areas in England were studied in a cross-sectional study. Demographic and risk factor data were collected and presence of microalbuminuria and overt proteinuria assessed. TRIAL REGISTRATION NUMBER: ISRCTN 38297969. MAIN OUTCOME MEASURES: Prevalences of microalbuminuria and overt proteinuria.
RESULTS: Urinary albumin:creatinine measurements were available for 1852 (94%) patients. The south Asian group had a lower prevalence of microalbuminuria, 19% vs. 23% and a higher prevalence of overt proteinuria, 8% vs. 3%, χ(2) = 15.85, 2df, P = 0.0004. In multiple logistic regression models, adjusted for confounding factors, significantly increased risk for the south Asian vs. white European patients for overt proteinuria was shown; OR (95% CI) 2.17 (1.05, 4.49), P = 0.0365. For microalbuminuria, an interaction effect for ethnicity and duration of diabetes suggested that risk for south Asian patients was lower in early years following diagnosis; OR for SA vs. WH at durations 0 and 1 year were 0.56 (0.37, 0.86) and 0.59 (0.39, 0.89) respectively. After 20 years' duration, OR = 1.40 (0.63, 3.08). LIMITATIONS: Comparability of ethnicity defined groups; statistical methods controlled for differences between groups, but residual confounding may remain. Analyses are based on a single measure of albumin:creatinine ratio.
CONCLUSIONS: There were significant differences between ethnicity groups in risk factor profiles and microalbuminuria and overt proteinuria outcomes. Whilst south Asian patients had no excess risk of microalbuminuria, the risk of overt proteinuria was elevated significantly, which might be explained by faster progression of renal dysfunction in patients of south Asian ethnicity.

Entities:  

Mesh:

Year:  2011        PMID: 22106977     DOI: 10.1185/03007995.2011.614937

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  5 in total

Review 1.  Risks of rapid decline renal function in patients with type 2 diabetes.

Authors:  Yi-Jing Sheen; Wayne Hh Sheu
Journal:  World J Diabetes       Date:  2014-12-15

2.  Low Rice Intake Is Associated with Proteinuria in Participants of Korea National Health and Nutrition Examination Survey.

Authors:  Se Jin Lee; So Young Lee; Su Ah Sung; Ho Jun Chin; Sung Woo Lee
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

3.  Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell function.

Authors:  Moneeza K Siddiqui; Ranjit Mohan Anjana; Adem Y Dawed; Cyrielle Martoeau; Sundararajan Srinivasan; Jebarani Saravanan; Sathish K Madanagopal; Alasdair Taylor; Samira Bell; Abirami Veluchamy; Rajendra Pradeepa; Naveed Sattar; Radha Venkatesan; Colin N A Palmer; Ewan R Pearson; Viswanathan Mohan
Journal:  Diabetologia       Date:  2022-03-05       Impact factor: 10.460

4.  Ability of a biomarker-based score to predict death from circulatory disease and cancer in NHANES III.

Authors:  Mieke Van Hemelrijck; Monika Eichholzer; David Faeh; Sabine Rohrmann
Journal:  BMC Public Health       Date:  2012-10-23       Impact factor: 3.295

5.  Clinical profile of long-term survivors and nonsurvivors with type 2 diabetes.

Authors:  Viswanathan Mohan; Coimbatore Subramanian Shanthi Rani; Anandakumar Amutha; Sravan Dhulipala; Ranjit Mohan Anjana; Balasubramanian Parathasarathy; Ranjit Unnikrishnan
Journal:  Diabetes Care       Date:  2013-04-05       Impact factor: 19.112

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.